NIH-funded research NIH-funded research

Improving treatment for ovarian cancer through advanced pathology services

Official title: Core B: TCP: Translational Pathology Core

Funded at University of Pittsburgh at Pittsburgh · NIH-10925291 · Data updated 2026-11-12

This study is all about improving how we understand and treat ovarian cancer by collecting important samples from patients, like tumor and blood samples, to help researchers create better, personalized treatments just for you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$322,900
NIH project number5P50CA272218-02
Project IDNIH-10925291 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals diagnosed with ovarian cancer who are receiving treatment at the Hillman Cancer Center.

Less likely to help

Patients with other types of cancer or those not receiving care at the Hillman Cancer Center may not benefit from this research.

What this research studies

This research focuses on enhancing the understanding and treatment of ovarian cancer by providing essential services such as procuring high-quality biospecimens and clinical data. The Translational Pathology Core at the Hillman Cancer Center will collect and process samples from patients, including tumor and blood specimens, to support innovative studies. These samples will be used to develop patient-derived tumor models and facilitate collaboration among researchers. By integrating various data types, the project aims to advance personalized treatment approaches for ovarian cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for patients with ovarian cancer.

How similar studies have gone: Previous research has shown success in using biorepositories and patient-derived models to advance cancer treatment, indicating that this approach is both promising and tested.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Modugno, Francesmary — University of Pittsburgh at Pittsburgh
  • Study coordinator: Modugno, Francesmary

Related research

Other NIH-funded projects on the same topics.

  • Elastomeric membranes for safer pelvic organ prolapse repair

    A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668074

  • Role of hyaluronan in egg development and ovarian reserve

    This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668041

  • Regulatory switches that control imprinting in early human development

    This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668004

  • Identifying molecular signs of imprinting errors linked to fertility treatments

    This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11667742

  • Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy

    A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645331

  • Spermatogonial stem cell transplantation and culture in patients

    Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645297

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.